Genevoyager at World Vaccine Congress Europe 2026

Oct 19–21, 2026 Amsterdam, Netherlands ~2k attendees Website

Genevoyager takes part in 1 session at World Vaccine Congress Europe 2026 in Amsterdam, and exhibits at Booth 428. Its program centres on cancer vaccines built on viral vectors, modified viruses that carry genetic instructions into cells. It covers the discovery stage of such a vaccine, linked to its contract work making viral vectors, proteins and vaccines.

OrganizationWorld Vaccine Congress Europe 2026 Attendance
Genevoyager
Wuhan, China
genevoyager.ltd
CRO, CDMO & labsSilver sponsor
One-stop CRO/CDMO for viral vectors, proteins and vaccines, with a large-scale AAV manufacturing platform and cGMP facilities.
Booth
Exhibiting at Booth 428
Talk
Mon Oct 19
10:45
Discovery of viral vector based cancer vaccine
Workshop: Cancer & Therapeutic Vaccines

Explore the full World Vaccine Congress Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Amsterdam. Leave your work email and we’ll be in touch.

Privacy

Download the full World Vaccine Congress Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Genevoyager

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Terrapinn or the World Vaccine Congress. Submit a correction